1 / 17

Presentation Outline

Presentation Outline. Market Background Regulatory Environment Industry Issues Intellectual Property Rights Growth Sectors Conclusions. NOTICE from CHCC. Only Selected Slides are Shown on our website Detailed Slides and Presentation can be available upon request.

louie
Download Presentation

Presentation Outline

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Presentation Outline • Market Background • Regulatory Environment • Industry Issues • Intellectual Property Rights • Growth Sectors • Conclusions China Healthcare Consulting

  2. NOTICE from CHCC • Only Selected Slides are Shown on our website • Detailed Slides and Presentation can be available upon request China Healthcare Consulting

  3. China- the fastest growing market in the world China Healthcare Consulting

  4. China- Import vs Export China Healthcare Consulting

  5. Strong Hard Currency Reserve China Healthcare Consulting

  6. Increasing U.S. Direct Investment into China China Healthcare Consulting

  7. China Pharmaceutical Industry Output & Growth Rate ---A Large and Growing Market China Healthcare Consulting

  8. China Pharmaceutical Commercial Sales & Growth Rate (Billion Yuan) China Healthcare Consulting

  9. 2001 2000 Company 1 1 Shanghai Roche 2 3 Shanghai BMS 3 2 Dalian Pfizer 4 7 Merck Sharp & Dohme 5 6 Glaxo 6 8 Beijing Double-Crane pharm. 7 10 Sino-Swed Pharm Corp 8 4 North China Group 9 5 Sandoz 10 12 Harbin Pharm. Group 11 16 Novartis 12 9 J&J 13 11 Astra-Zeneca 14 17 Bayer 15 34 Shandon Lu Nan Pharm. Rank of Drug sales in 14 major area 2001China China Healthcare Consulting

  10. Problems in Healthcare System • Lack of Stable Budget Resources • Great Variability in Ability to Pay by Employers • Casual Attitudes toward Medical Expenditure • Incompatible with New Ownership Structure • Deferred Payment Causes Resentment and Social Problems China Healthcare Consulting

  11. SDA • Merger of 3 Former Governmental Departments • Composition • Department of Drug Registration • Synthetic, Biological and TCM Divisions • Department of Medical Devices • Standards, Product Registration and Supervision Divisions • Department of Safety Supervision • Department of Market Compliance China Healthcare Consulting

  12. IPR • Counterfeiting of Trademarks • Lax Enforcement of Law and Protection of Local Industry • WTO Accession Exempts China From Giving Immediate Patent Protection • Administrative Protection (AP) is Rumoured to be Phased Out in Favour of 20-Year Patent • Pre-AP Local Generics Considered Legal • Requirement of Large Generic Prints on Labels China Healthcare Consulting

  13. WTO Challenges (1) • Regulatory Environment • More in Line With International Standards • More Transparent Administration • ICH Guideline Increasingly More Relevant • Administrative Barriers to Offset WTO Requirements China Healthcare Consulting

  14. Biological Products • Types • Biochemical, Biological and Genetically Engineered Products • Science and Technology Driven • Average Growth Rate 12.5% Worldwide Compared with 8% for Pharmaceuticals • US$ 20 Billion in 2000 with 100+ Products China Healthcare Consulting

  15. OTC Market in China • 700 OTC, 70 % will be registered as OTC • Urbanization. Large migration from rural • Sales by chain pharmacies in coastal cities increased by 45% in 2001. • Foreign companies allowed to run OTC distribution China Healthcare Consulting

  16. TCM: Traditional Chinese Medicine • TCM Source Materials Number Over 12,000 • TCM Industry Produces 5,000+ TCM Preparations in Large-Scale Production • TCM Sector Outperforms Average Medical Industry’s Performance Indicators • Ride on the Back of Strong Worldwide Demand for Natural Medicines China Healthcare Consulting

  17. MORE • Chinese Hospitals • China’s healthcare system China Healthcare Consulting

More Related